Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Open Label Trial of Tolerability and Efficacy of Oral Letermovir for CMV Prophylaxis Among Heart and Lung Transplant Recipients

NCT06066957 is registered in ClinicalTrials.gov with University of Pennsylvania as lead sponsor.

NCT NCT06066957
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06066957 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Open Label Trial of Tolerability and Efficacy of Oral Letermovir for CMV Prophylaxis Among Heart and Lung Transplant Recipients
Lead sponsor
University of Pennsylvania
Phase
Phase 2
Overall status
Active, not recruiting
Start date
April 4, 2024
Completion date
January 31, 2027
Enrollment
80 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cytomegalovirus infections, transplant-related disorder